Phase II study of the combination of gemcitabine plus carboplatin as neoadjuvant treatment in locally advanced breast cancer

被引：0
|
作者：
Srimuninnimit, V. [1 ]
Ithimakin, S. [1 ]
Akewanlop, C. [1 ]
Ratanawichitrasin, A. [1 ]
Veerasan, V. [1 ]
Rojananin, S. [1 ]
Prasartong-osoth, P. [1 ]
机构：
[1] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.652
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
652
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer
    Iwasaki, Kazuhiro
    Obara, Wataru
    Kato, Yoichiro
    Takata, Ryo
    Tanji, Susumu
    Fujioka, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (02) : 193 - 199
  • [2] Neoadjuvant administration of gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in large or locally advanced operable breast cancer: a phase II study.
    Chacko, RT
    Julka, PK
    Parshad, R
    Nair, A
    Nag, S
    Dhindsa, N
    Koppiker, CB
    Nair, S
    Abhyankar, JR
    Dawar, R
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S109 - S110
  • [3] Gemcitabine plus carboplatin in recurrent and advanced breast cancer: A phase II trial.
    Silva, JA
    Michel, LMP
    Rincon, DG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 95S - 95S
  • [4] Phase II Study of Neoadjuvant Gemcitabine, Pegylated Liposomal Doxorubicin, and Docetaxel in Locally Advanced Breast Cancer
    Grazia, Artioli
    Simone, Mocellin
    Lucia, Borgato
    Alessandro, Cappetta
    Fernando, Bozza
    Giorgio, Zavagno
    Stefania, Zovato
    Alberto, Marchet
    Davide, Pastorelli
    ANTICANCER RESEARCH, 2010, 30 (09) : 3817 - 3821
  • [5] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, D.
    Scalone, S.
    Crivellari, D.
    La Mura, N.
    Miolo, G.
    Murrone, A.
    Perin, T.
    Coran, F.
    Candiani, E.
    Massarut, S.
    Veronesi, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [6] Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II study
    Lombardi, Davide
    Scalone, Simona
    Crivellari, Diana
    Magri, Maria Donatella
    La Mura, Nicoletta
    Miolo, GianMaria
    Murrone, Antonio
    Perin, Tiziana
    Coran, Francesco
    Candiani, Ezio
    Massarut, Samuele
    Veronesi, Andrea
    TUMORI JOURNAL, 2010, 96 (02): : 229 - 233
  • [7] A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
    Jeon, Ye Won
    Kim, Tae Hyun
    Youn, Hyun Jo
    Han, Sehwan
    Jung, Yongsik
    Gwak, Geumhee
    Park, Young Sam
    Kim, Jeong Soo
    Suh, Young Jin
    JOURNAL OF BREAST CANCER, 2017, 20 (04) : 340 - 346
  • [8] Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis
    Mofid, Bahram
    Razzaghdoust, Abolfazl
    Ghajari, Mahdi
    Basiri, Abbas
    Fattahi, Mohammad-Reza
    Houshyari, Mohammad
    Jafari, Anya
    Taghizadeh-Hesary, Farzad
    UROLOGY JOURNAL, 2022, 19 (05) : 371 - 378
  • [9] The Combination of Gemcitabine and Carboplatin in Neoadjuvant Treatment of Bladder Cancer: A Pilot Study
    Dizdar, Omer
    Akbulut, Ziya
    Tuna, Savas
    Cavusoglu, Emel
    Ulusoy, Nuran A.
    Balbay, M. Derya
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (02): : 67 - 70
  • [10] Neoadjuvant chemoimmunotherapy with cisplatin, gemcitabine plus GM-CSF in locally advanced oesophageal cancer: a phase II study
    Veenhof, A. A. F. A.
    Scheepers, J. J. G.
    van Groeningen, C. J.
    Peters, G. J.
    Bloemena, E.
    Craanen, M. E.
    Meijerink, W. J. H. J.
    Cuesta, M. A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : A31 - A31
12345